Uromigos Live 2023: First-line Bladder Cancer: What Just Happened?
By The Uromigos - Last Updated: November 20, 2023During the second-annual Uromigos Live & Unplugged event, Brian Rini, MD; Thomas Powles, MBBS, MRCP, MD; Matthew Galsky, MD; Jonathan Rosenberg, MD; and Shilpa Gupta, MD met on stage as the first bladder cancer panel.
Together, they discussed the latest data and updates in frontline bladder cancer during a livestreamed session.
View the second bladder cancer session of the day on non-muscle invasive disease.
Post Tags:Uromigos Live 2023-Bladder Cancer
Related Posts
Dr. Powles chaired a livestreamed RCC session that included lively discussion from Drs. Atkins, McDermott, and Rini.
The panel highlights a serious of relevant studies in renal cell carcinoma, including CONTACT-03 and TiNivo-2.
The panel discusses data related to RLTs in prostate cancer, including a recap of the VISION trial and the PSMAfore trial.
The panel breaks down the details of the PROpel, TALAPRO-2, and MAGNITUDE trials along with relevant rPFS and HR data.
The panel discussed the latest updates in NMIBC, including relevant data pertaining to pembro, atezo, and more.
630 Madison Ave.
Manalapan, NJ 07726
© 2023 Mashup Media, LLC. All rights reserved.